" class="no-js "lang="en-US"> Tumors Archives - Medtech Alert
Wednesday, March 22, 2023

Sort by:

Date

Top Post

Porton Advanced and Bennu Biotherapeutics Announced a Strategic Partnership to Accelerate Cell Therapy Development for Solid Tumors

Porton Advanced Solutions and Bennu Biotherapeutics have announced a strategic partnership to advance cell and […]

Fore Biotherapeutics Announces First Patient Dosed in Global Phase 2 Trial Evaluating FORE8394 in BRAF-Mutated Solid and Brain Tumors

Fore Biotherapeutics, a precision oncology company dedicated to developing innovative treatments that provide a better […]

Phio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial to Treat Solid Tumors

Phio Pharmaceuticals has announced their clinical development partner, AgonOx, has received confirmation from the FDA […]

AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets

AbbVie and Immunome,  a clinical-stage biopharmaceutical company that utilizes its human memory B cell platform […]

Orano Med Starts Phase I Trial With Alpha Radioligand Therapy 212Pb-GRPR in Patients With Solid Tumors

Orano Med, a clinical stage radiopharmaceutical company, has announced that the first patient has been […]

  1. Axel Hoos, MD, PhD, Joins NextPoint Therapeutics Board of Directors Read more
  2. Coya Therapeutics Announces Positive Results from a Proof-of-Concept Academic Clinical Study for COYA 302 in Amyotrophic Lateral Sclerosis (ALS) Read more
  3. BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint in New Jersey Read more
  4. Mindset Health Raises $12M to Expand Digital Hypnotherapy Apps & Scale Distribution Read more
  5. GeneDx Announces Progress on GUARDIAN Study and Promise of Early Genomic Testing to End Rare Disease “Diagnostic Odyssey” Read more